Fairfield, Bush & Co’s bluebird bio BLUE Stock Holding History

Fairfield, Bush & Co’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-154	Closed	-$292K	–	149
2018 Q3	$292K	Hold	154	–	–	0.08%	137
2018 Q2	$314K	Hold	154	–	–	0.09%	134
2018 Q1	$342K	Hold	154	–	–	0.1%	127
2017 Q4	$356K	Hold	154	–	–	0.1%	121
2017 Q3	$275K	Hold	154	–	–	0.09%	128
2017 Q2	$210K	Buy	+154	New	+$186K	0.07%	138
2016 Q1	–	Sell	-309	Closed	-$257K	–	136
2015 Q4	$257K	Buy	+309	New	+$309K	0.09%	124
2015 Q3	–	Sell	-154	Closed	-$337K	–	141
2015 Q2	$337K	Hold	154	–	–	0.1%	131
2015 Q1	$242K	Buy	+154	New	+$203K	0.07%	154

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fairfield, Bush & Co's BLUE Position: Q4 2018 in Review

Fairfield, Bush & Co sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 154 shares — an estimated $292K sold.

Fairfield, Bush & Co first reported a position in BLUE in Q1 2015 and held it in 9 quarters. The position peaked at $356K in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

Fairfield, Bush & Co reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
Fairfield, Bush & Co sold 154 bluebird bio shares in Q4 2018, an estimated $292K.
Fairfield, Bush & Co first reported a position in bluebird bio in Q1 2015 and held it in 9 quarters.
Fairfield, Bush & Co's bluebird bio position peaked at $356K in Q4 2017.
251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Fairfield, Bush & Co's 13F filing for Q4 2018, filed 11 Feb 2019.